SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Safeguard Scientifics SFE

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: David Lawrence who wrote (2023)11/24/1998 11:47:00 AM
From: John Arnopp  Read Replies (1) of 4467
 
Good points.

The only benefit served is to reduce the number of outstanding shares, which reduces the number of rights offering shares they will have to sell in each offering. If we assume they were able to buy back about 2mm shares with their combined $40mm, this would mean 400K less rights they could sell, allowing them to retain those shares. At $5 they would be worth $2mm, or about $1 per share purchased. Still not a good investment unless the premium is $3 or less (at 3 offerings per year) - or if the future companies would trade above $5.

Leads to a good strategy for investors, though, especially in the absence of offerings: When there is a premium, buy the most beaten down public companies (anyone for more USDC?) and when there is a discount, buy SFE.

--John
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext